| Family: | ProShares |
| Name: | ProShares UltraShort Nasdaq Biotechnology |
| Inception Date: | 7-Apr-2010 |
| Termination Date: | |
| Investment Objective: | ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index. |
| Prospectus | |
| Top 10 Holdings | ||
| Derivatives offset | 200.5334% | |
| Net Other Assets (Liabilities) | 100.0000% | |
| NASDAQ Biotechnology Index SWAP Bank of America NA | -64.7672% | |
| NASDAQ Biotechnology Index SWAP Citibank NA | -35.6108% | |
| NASDAQ Biotechnology Index SWAP UBS AG | -34.9431% | |
| NASDAQ Bio Index SWAP BNP Paribas | -33.6077% | |
| NASDAQ Biotechnology Index SWAP Societe Generale | -31.6046% | |
| Top 10 Holdings Weight: | 100.0% |
| Number of Holdings: | 7 |
| Shares Outstanding: | 165,520 |
| Total Net Assets: | 2,704,514 |
| NAV: | 16.34 |
| Net Expense Ratio: | 0.95% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | Inverse (-2x) |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
